Interactions between Effectors Linked to Serotonin Receptors
暂无分享,去创建一个
[1] P. Leff,et al. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.
[2] P. Leff,et al. A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.
[3] G. Milligan,et al. Up‐regulation of a constitutively active form of the β 2‐adrenoceptor by sustained treatment with inverse agonists but not antagonists , 1996, FEBS letters.
[4] G. Milligan,et al. Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells. , 1996, Molecular pharmacology.
[5] S. Maayani,et al. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. , 1996, Molecular pharmacology.
[6] G. Martin,et al. Characterization of a 5‐HT1B receptor on CHO cells: functional responses in the absence of radioligand binding , 1996, British journal of pharmacology.
[7] I. Forbes,et al. In vitro and in vivo profile of SB 206553, a potent 5‐HT2C/5‐HT2B receptor antagonist with anxiolytic‐like properties , 1996, British Journal of Pharmacology.
[8] S. Siegelbaum,et al. Hippocampal long-term depression: Arachidonic acid as a potential retrograde messenger , 1995, Neuropharmacology.
[9] M. Kaufman,et al. Serotonin 5‐HT2C Receptor Stimulates Cyclic GMP Formation in Choroid Plexus , 1995, Journal of neurochemistry.
[10] A. Saltzman,et al. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. , 1994, Molecular pharmacology.
[11] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[12] R. McKay,et al. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. , 1994, Molecular pharmacology.
[13] E. sanders-Bush,et al. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. , 1993, Molecular pharmacology.
[14] B. Hoffman,et al. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. , 1992, Molecular pharmacology.
[15] M. Kaufman,et al. The 5‐HT1C Receptor , 1990, Annals of the New York Academy of Sciences.
[16] Takao Shimizu,et al. Arachidonic Acid Cascade and Signal Transduction , 1990, Journal of neurochemistry.
[17] S. Svebak,et al. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. , 1990, The Journal of clinical psychiatry.
[18] J. Axelrod,et al. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Murphy,et al. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. , 1988, Pharmacological reviews.
[20] P. Conn,et al. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. Conn,et al. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. , 1985, The Journal of pharmacology and experimental therapeutics.